Dehmel U, Zaborski M, Meierhoff G, Rosnet O, Birnbaum D, Ludwig W D, Quentmeier H, Drexler H G
Department of Human and Animal Cell Cultures, German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany.
Leukemia. 1996 Feb;10(2):261-70.
The growth of cells in vitro and in vivo is regulated by several environmental signals among which growth factors (cytokines) figure prominently. FLT3 is a novel cytokine receptor with intrinsic ligand-stimulated (FLT3 ligand, FL) tyrosine kinase activity. Here, using a specific anti-FLT3 monoclonal antibody (McAb) and flow cytometry we determined the expression pattern of the receptor protein in 55 human leukemia-lymphoma cell lines and in 20 primary samples from patients with acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML). FLT3 receptor surface expression was found predominantly in pre-B cell, myeloid and monocytic cell lines and in pre-B-ALL and AML cells, FL was overexpressed in baby hamster kidney cells producing a recombinant protein that was functional in receptor binding and signaling. Incubation with FL induced 3H-thymidine uptake-measured proliferation in some myeloid cell lines and in 2/9 AML cases. The strongest proliferative response was seen in the two growth factor-dependent myeloid leukemia cell lines MUTZ-2 and OCI-AML-5. Long-term substitution of the commonly used cytokines with FL sustained the continuous proliferation of these two cell lines suggesting that also upon permanent activation FLT2 can function as a mitogenic signaling molecule. Despite the high density of FLT3 receptor expression on cultured and fresh pre-B-ALL cells, no proliferation could be stimulated in any of these specimens. Incubation with the anti-FLT3 McAb had agonistic proliferative effects in MUTZ-2 and OCI-AML-5; and anti-FL reagent blocked FL-stimulated proliferation. To summarize, we demonstrated that FL is effective in inducing proliferation of leukemic myeloid cells and that protein expression does not necessarily indicate an FL-responsive cell. While the present data clearly demonstrate that FL might play a proliferative role in leukemogenesis, further studies are needed to clarify whether the signals provided by FL:FLT3 interaction are confined to a proliferation-inducing function or whether maturational progression could also be elicited in certain cells.
细胞在体外和体内的生长受多种环境信号调控,其中生长因子(细胞因子)起着重要作用。FLT3是一种新型细胞因子受体,具有内在的配体刺激(FLT3配体,FL)酪氨酸激酶活性。在此,我们使用特异性抗FLT3单克隆抗体(McAb)和流式细胞术,确定了55个人类白血病-淋巴瘤细胞系以及20例急性淋巴细胞白血病(ALL)或急性髓细胞白血病(AML)患者的原发性样本中该受体蛋白的表达模式。FLT3受体表面表达主要见于前B细胞、髓细胞和单核细胞系以及前B-ALL和AML细胞,FL在产生重组蛋白的幼仓鼠肾细胞中过表达,该重组蛋白在受体结合和信号传导方面具有功能。用FL孵育可诱导某些髓细胞系和2/9例AML病例中3H-胸腺嘧啶摄取量测定的增殖。在两个依赖生长因子的髓细胞白血病细胞系MUTZ-2和OCI-AML-5中观察到最强的增殖反应。用FL长期替代常用细胞因子可维持这两个细胞系的持续增殖,表明FLT2在持续激活时也可作为有丝分裂信号分子发挥作用。尽管培养的和新鲜的前B-ALL细胞上FLT3受体表达密度很高,但在任何这些样本中均未刺激增殖。用抗FLT3 McAb孵育在MUTZ-2和OCI-AML-5中具有激动性增殖作用;抗FL试剂可阻断FL刺激的增殖。总之,我们证明FL可有效诱导白血病髓细胞增殖,且蛋白表达不一定表明细胞对FL有反应。虽然目前的数据清楚地表明FL可能在白血病发生中起增殖作用,但需要进一步研究以阐明FL:FLT3相互作用提供的信号是否仅限于诱导增殖功能,或者在某些细胞中是否也能引发成熟进程。